Kala Bio, Inc. (KALA)
0.7861
-0.05
(-6.23%)
USD |
NASDAQ |
Dec 09, 16:00
0.7771
-0.01
(-1.14%)
After-Hours: 05:14
Kala Bio Total Liabilities (Quarterly): 33.69M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Q32 Bio, Inc. | 76.23M |
| PharmaCyte Biotech, Inc. | 1.519M |
| Allogene Therapeutics, Inc. | 124.44M |
| Akero Therapeutics, Inc. | 47.94M |
| Belite Bio, Inc. | 8.311M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 25.02M |
| Shareholders Equity (Quarterly) | -8.665M |
| Debt to Equity Ratio | -3.456 |
| Current Ratio | 0.7452 |
| Net Debt Paydown Yield | 12.06% |